Literature DB >> 2370898

Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis.

M Fukagawa, R Okazaki, K Takano, S Kaname, E Ogata, M Kitaoka, S Harada, N Sekine, T Matsumoto, K Kurokawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2370898     DOI： 10.1056/NEJM199008093230617

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  Percutaneous autotransplantation of parathyroid tissue into the forearm muscles.

Authors:  H Hidai; T Chiba; Y Takagi; T Mori; T Taniguchi; T Hyodo
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

2.  The management of renal osteodystrophy.

Authors:  I B Salusky; W G Goodman
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

3.  Preventing bone disease requires diligent management in patients with renal failure.

Authors:  F O Kolb
Journal:  West J Med       Date:  1994-05

4.  US imaging and color Doppler in patients undergoing inhibitory therapy with calcitriol for secondary hyperparathyroidism.

Authors:  F Pretolesi; E Silvestri; G Di Maio; C Martinoli; F Onetto; P Sala; L E Derchi
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

5.  1.25(OH)2 cholecalciferol pulse therapy and the effects of different dialysis membranes on serum PTH levels of haemodialysis patients.

Authors:  M Boran; E Doruk; F Gönenç; S Cetin
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

Review 6.  Regulation of parathyroid function in chronic kidney disease (CKD).

Authors:  Masafumi Fukagawa; Shohei Nakanishi; Hideki Fujii; Yasuhiro Hamada; Takaya Abe
Journal:  Clin Exp Nephrol       Date:  2006-09       Impact factor: 2.801

7.  The case for routine parathyroid hormone monitoring.

Authors:  Stuart M Sprague; Sharon M Moe
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-04       Impact factor: 8.237

8.  Molecular and morphological approach of uremia-induced hyperplastic parathyroid gland following direct maxacalcitol injection.

Authors:  Kazuhiro Shiizaki; Ikuji Hatamura; Eiko Nakazawa; Manabu Ogura; Takahiro Masuda; Tadao Akizawa; Eiji Kusano
Journal:  Med Mol Morphol       Date:  2008-07-01       Impact factor: 2.309

9.  Chronotherapy of high-dose active vitamin D3 in haemodialysis patients with secondary hyperparathyroidsm: a repeated dosing study.

Authors:  Shuichi Tsuruoka; Michi Wakaumi; Koichi Sugimoto; Tetsuo Saito; Akio Fujimura
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

Review 10.  Calcitriol administration in end-stage renal disease: intravenous or oral?

Authors:  L D Quarles; O S Indridason
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.